수의용 참조 실험실 시장 규모, 점유율, 동향 분석 보고서 : 동물별, 용도별, 기술별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Veterinary Reference Laboratory Market Summary

The global veterinary reference laboratory market size was estimated at USD 5.35 billion in 2025 and is projected to reach USD 12.08 billion by 2033, growing at a CAGR of 10.87% from 2026 to 2033. The market is experiencing growth driven by factors such as growing awareness of early disease detection in companion animals, expansion of diagnostic capacity through laboratory acquisitions and network build-outs, increasing public investment in zoonotic disease surveillance and food safety, and rising demand for specialized and high-complexity testing.

A major factor driving the market is that more people now understand the importance of early disease detection and monitoring in animals. Pet owners, livestock producers, and veterinarians are focusing more on catching health problems before they get worse. Because of this, there is greater demand for veterinary reference laboratories. These labs offer specialized tests that smaller clinics often cannot perform, including complex molecular tests, histopathology, and wide-ranging infectious disease panels. As a result, more samples are being sent to reference labs for accurate and timely diagnoses.

Demand is growing in the companion animal segment because owners want thorough health checks for older pets and those showing mild symptoms. Finding conditions like cancer, endocrine problems, and infections early helps improve treatment results. Reference labs meet this need by offering advanced tests and expert analysis, which leads to more referrals and greater use of centralized diagnostic services. In the livestock sector, producers are also sending more samples as they work to control outbreaks that threaten herd health and productivity. Reference labs help by providing confirmatory tests and surveillance tools to guide herd management.

Public health agencies are also supporting this trend by expanding programs to monitor zoonotic threats and food safety risks. These programs depend on standardized methods and reports from accredited reference labs. Private investment is helping labs grow, as diagnostic companies build new facilities and form partnerships. These steps help reduce turnaround times and expand service areas. As more clinicians and animal health managers see the value of early diagnosis, demand for reference lab services keeps rising. This ongoing trend is driving steady market growth and encouraging more investment in advanced diagnostic infrastructure.

Global Veterinary Reference Laboratory Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the veterinary reference laboratory market report based on animal, technology, application, end use, and region:

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals
• Production Animals
  • Cattles
  • Pigs
  • Poultry
  • Sheep and Goats
  • Other Production Animals
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Chemistry
• Hematology
• Immunodiagnostic
  • ELISA Tests
  • Lateral Flow Rapid Tests
  • Others
• Molecular Diagnostics
  • PCR Tests
  • Microarrays
  • Others
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Pathology
• Virology
• Bacteriology
• Parasitology
• Productivity Testing
• Pregnancy Testing
• Toxicology
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• Academic & Research Institutions
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Animal
  • 1.2.2. Technology
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Bottom-Up Analysis
  • 1.7.2. Model 2: Volume-Pricing Analysis
  • 1.7.3. Model 3: Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing awareness of early disease detection in companion animals
    • 3.2.1.2. Expansion of diagnostic capacity through laboratory acquisitions and network build-outs
    • 3.2.1.3. Increasing public investment in zoonotic disease surveillance and food safety
    • 3.2.1.4. Rising demand for specialized and high-complexity testing
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Heightened regulatory oversight following disease outbreaks
    • 3.2.2.2. High capital intensity and shortage of skilled veterinary diagnosticians
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Pricing Analysis
• 3.4. Market Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL by SWOT Analysis
• 3.5. Estimated Animal Population, by Key Species & Key Countries, 2025

Chapter 4. Veterinary Reference Laboratory Market: Animal Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Reference Laboratory Market, By Animal Movement Analysis
• 4.3. Veterinary Reference Laboratory Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 4.4. Companion Animals
  • 4.4.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.1. Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Other Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5.1. Other Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Production Animals
  • 4.5.1. Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Cattle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.1. Cattle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Pigs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.1. Pigs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4.1. Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Sheep & Goats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5.1. Sheep & Goats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.6. Other Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6.1. Other Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Reference Laboratory Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Reference Laboratory Market, By Technology Movement Analysis
• 5.3. Veterinary Reference Laboratory Market Estimates & Forecasts, by Technology, 2021 to 2033 (USD Million)
• 5.4. Clinical Chemistry
  • 5.4.1. Clinical Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Hematology
  • 5.5.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Immunodiagnostic
  • 5.6.1. Immunodiagnostic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. ELISA Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2.1. ELISA Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Lateral Flow Rapid Test Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3.1. Lateral Flow Rapid Test Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.4. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Molecular Diagnostics
  • 5.7.1. Molecular Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. PCT Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.2.1. PCR Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.3. Microarrays Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.3.1. Microarrays Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.4. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others Animals
  • 5.8.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Reference Laboratory Market: By Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Reference Laboratory Market, By Application Movement Analysis
• 6.3. Veterinary Reference Laboratory Market Estimates & Forecasts, By Application, 2021 to 2033 (USD Million)
  • 6.3.1. Clinical Pathology
    • 6.3.1.1. Clinical Pathology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Virology
    • 6.3.2.1. Virology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Bacteriology
    • 6.3.3.1. Bacteriology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Parasitology
    • 6.3.4.1. Parasitology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.5. Productivity Testing
    • 6.3.5.1. Productivity Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.6. Pregnancy Testing
    • 6.3.6.1. Pregnancy Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.7. Toxicology
    • 6.3.7.1. Toxicology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.8. Others
    • 6.3.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Reference Laboratory Market: By End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Reference Laboratory Market, By End Use Movement Analysis
• 7.3. Veterinary Reference Laboratory Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
  • 7.3.1. Veterinary Hospitals & Clinics
    • 7.3.1.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Academic & Research Institutions
    • 7.3.2.1. Academic & Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Others
    • 7.3.3.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Reference Laboratory Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. IDEXX
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product/Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Mars, Incorporated
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product/Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. GD
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product/Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Greencross Vets
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product/Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Gribbles Veterinary Pathology
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product/Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Zoetis
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product/Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Ellie Diagnostics
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product/Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Neogen Corporation
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product/Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. ProtaTek International, Inc.
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product/Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Wisconsin Veterinary Diagnostic Laboratory
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product/Service Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. Merck & Co., Inc.
    • 9.3.11.1. Participant's Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Product/Service Benchmarking
    • 9.3.11.4. Strategic Initiatives